Doctors Kept Close Eye on Trump's Use of Malaria Drug

Thursday, 4 June 2020 18:52 WIB



The White House medical team kept a close eye on President Donald Trump's heart rhythms, including at least one electrocardiogram, to watch for potential side effects when he took a two-week course of a malaria drug to try to prevent the coronavirus, his doctor reported Wednesday.

"The President completed the regimen safely and without side effects," Dr. Sean Conley wrote in a report on Trump's latest physical and his treatment with hydroxychloroquine.

Overall, Conley said, Trump showed little change in basic health measurements from 16 months ago. On the negative side, he gained a pound. But on the plus side, his cholesterol level continued to fall.

"The data indicates the President remains healthy," Conley concluded.

Trump recently took a two-week course of hydroxychloroquine after two White House staffers tested positive for COVID-19.

Conley said it was done in consultation with "appropriate care team members and close monitoring of the electrocardiogram (EKG)," indicating that doctors were looking for changes in his heartbeat because abnormal heart rhythms are one of the dangerous side effects that have been found in studies of the drug.

The drug proved ineffective for preventing COVID-19 in the first large, high-quality study to test it in people in close contact with someone with the disease. Results published Wednesday by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the coronavirus. The drug did not seem to cause serious harm, though — about 40% on it had side effects, mostly mild stomach problems.

Trump has frequently cited anecdotal reports and seemed determined to prove the naysayers wrong.

Trump's weight came in a 244 pounds. That gives him a Body Mass Index of 30.5, based on his 6-foot, 3-inch frame. An index rating of 30 is the level at which doctors consider someone to be obese. About 40% of Americans are obese.

Source : VOA




Seluruh materi atau konten yang tersaji di dalam website ini hanya bersifat informatif saja, dan tidak dimaksudkan sebagai pegangan serta keputusan dalam investasi atau jenis transaksi lainnya. Kami tidak bertanggung jawab atas segala akibat yang timbul dari penyajian konten tersebut. Semua pihak yang mengunjungi website ini harus membaca Terms of Service (Syarat dan Ketentuan Layanan) terlebih dahulu dan dihimbau untuk melakukan analisis secara independen serta memperoleh saran dari para ahli dibidangnya.